Fasting glucose high but HbA1c normal is a puzzling combination that many people encounter after routine blood tests. These two measurements assess blood sugar regulation in fundamentally different ways — fasting plasma glucose captures a single snapshot, whilst HbA1c reflects average levels over two to three months. It is entirely possible for them to produce apparently contradictory results, and understanding why matters. This article explains the common causes of this discrepancy, how the NHS interprets both results together, when to seek a GP review, and what lifestyle and monitoring steps are recommended to protect your long-term metabolic health.

What It Means When Fasting Glucose Is High but HbA1c Is Normal

A raised fasting glucose alongside a normal HbA1c suggests blood sugar may be rising acutely — particularly in the morning — without sustained elevation throughout the day, warranting clinical interpretation rather than dismissal.

Receiving a blood test result showing a raised fasting glucose alongside a normal HbA1c can be confusing and understandably concerning. These two tests measure different aspects of blood sugar regulation, and it is entirely possible — though worth investigating — for them to give apparently contradictory results.

Fasting plasma glucose measures the concentration of glucose in your blood after a period of at least eight hours without eating. In the UK, a normal fasting plasma glucose is generally below 6.1 mmol/L (though individual laboratory reference ranges may vary slightly). Levels between 6.1 and 6.9 mmol/L are classified as impaired fasting glucose (IFG) — also referred to in UK services as non-diabetic hyperglycaemia (NDH) — and a level of 7.0 mmol/L or above on two separate occasions (or once in a symptomatic individual) indicates diabetes.

HbA1c, by contrast, reflects your average blood glucose over the preceding two to three months. It measures the proportion of haemoglobin — the protein in red blood cells — that has become glycated (coated with glucose). A normal HbA1c is below 42 mmol/mol (6.0%), with 42–47 mmol/mol indicating non-diabetic hyperglycaemia (prediabetes risk) and 48 mmol/mol or above meeting the diagnostic threshold for type 2 diabetes.

It is important to note that HbA1c is not appropriate for diagnosing diabetes in all situations. It should not be used as a diagnostic test in:

• Pregnancy (including suspected gestational diabetes)

• Children and young people

• Suspected type 1 diabetes or acute-onset hyperglycaemia

• Acute illness

• Advanced chronic kidney disease (CKD stage 4–5)

• People with certain haemoglobin variants or conditions affecting red blood cell turnover, where assay results may be unreliable

In these circumstances, glucose-based tests (fasting plasma glucose, random plasma glucose, or oral glucose tolerance test) are preferred.

When fasting glucose is elevated but HbA1c remains within the normal range, it suggests that blood sugar may be rising acutely — particularly in the morning — without sustained elevation throughout the day. This discrepancy does not necessarily mean diabetes is present, but it does warrant careful clinical interpretation rather than dismissal.

Common Reasons for This Discrepancy in Blood Sugar Results

The most common causes include the dawn phenomenon, acute stress, haematological conditions that falsely lower HbA1c, haemoglobin variants, and medicines such as corticosteroids or atypical antipsychotics.

There are several well-recognised physiological and technical explanations for why fasting glucose may be elevated whilst HbA1c remains normal.

The dawn phenomenon is one possible cause. In the early morning hours, the body naturally releases hormones — including cortisol, glucagon, and growth hormone — that signal the liver to release stored glucose in preparation for waking. In some individuals, this hormonal surge produces a more pronounced rise in fasting blood glucose, even when overall glucose control throughout the day is satisfactory. This effect is more commonly described in people with established diabetes, but may occasionally occur in those without a diagnosis.

Acute stress or illness at the time of the blood test can also transiently raise fasting glucose. Stress hormones such as adrenaline and cortisol are potent drivers of hepatic glucose output and can produce a temporarily elevated reading that does not reflect habitual glucose levels.

Haematological conditions and assay factors can affect HbA1c reliability in specific ways:

• Conditions that shorten red blood cell lifespan — such as haemolytic anaemia, acute blood loss, or erythropoietin therapy in CKD — reduce the time available for haemoglobin glycation, producing a falsely low HbA1c. This means HbA1c may appear normal even when glucose levels have been genuinely elevated.

• Conditions that prolong red cell survival or impair red cell turnover — such as iron deficiency anaemia, vitamin B12 or folate deficiency, or asplenia — tend to produce a falsely high HbA1c.

• Haemoglobin variants (such as HbS, HbC, or HbE) can interfere with certain HbA1c assay methods, causing results to be unreliable regardless of direction. In these cases, glucose-based tests should be used instead.

UK HbA1c assays are standardised to IFCC methodology, so significant laboratory-to-laboratory variability is uncommon; pre-analytical factors (such as insufficient fasting, acute illness, or recent medication changes) are more likely explanations for unexpected results.

Other contributing factors include:

• Recent dietary changes or a high-carbohydrate meal the evening before the test

• Certain medicines, including systemic corticosteroids, atypical antipsychotics (such as olanzapine or clozapine), thiazide diuretics, and beta-blockers — all of which can raise blood glucose

• Dehydration, which can concentrate blood glucose

Understanding the likely cause is essential before drawing clinical conclusions from a single discordant result.

How the NHS Interprets Fasting Glucose and HbA1c Together

NICE guidance requires two qualifying results on separate occasions to diagnose diabetes in asymptomatic adults; a raised fasting glucose with normal HbA1c may indicate non-diabetic hyperglycaemia, not diabetes.

The NHS and NICE guidance (NG28 and associated updates) recognise that no single blood test is infallible, and that clinical interpretation should consider both results in context.

According to NICE guidance, the approach to diagnosis differs depending on whether symptoms are present:

• In symptomatic adults (for example, those with thirst, polyuria, or unexplained weight loss), a single abnormal result is usually sufficient to confirm a diagnosis of diabetes without delay:
• Fasting plasma glucose ≥7.0 mmol/L, or
• Random plasma glucose ≥11.1 mmol/L, or

• HbA1c ≥48 mmol/mol

• In asymptomatic adults, the result should be confirmed on a separate occasion before a diagnosis is made. Two qualifying results are required.

If fasting glucose is in the impaired range (6.1–6.9 mmol/L) but HbA1c is below 42 mmol/mol, this may indicate isolated impaired fasting glucose (IFG), classified in UK services as non-diabetic hyperglycaemia (NDH). This is considered a risk state for future type 2 diabetes and cardiovascular disease, but does not itself constitute a diagnosis of diabetes. Eligibility for the NHS Diabetes Prevention Programme (NHS DPP) is typically based on an HbA1c of 42–47 mmol/mol or a fasting plasma glucose of 5.5–6.9 mmol/L, depending on local referral criteria.

In some cases, a clinician may request an oral glucose tolerance test (OGTT), which measures blood glucose before and two hours after consuming a standardised glucose drink. OGTT thresholds are:

• 2-hour glucose 7.8–11.0 mmol/L = impaired glucose tolerance (IGT)

• 2-hour glucose ≥11.1 mmol/L = diabetes

The OGTT is the gold standard for diagnosing gestational diabetes and is sometimes used when other results are inconclusive. HbA1c should not be used to diagnose diabetes in pregnancy; glucose-based testing is required.

Remember that HbA1c is not appropriate in all diagnostic situations — see the first section for a list of circumstances where glucose-based tests should be preferred.

When to Seek Further Testing or a GP Review

A GP review is advisable for any fasting glucose of 6.1 mmol/L or above, particularly if symptoms such as thirst, polyuria, or fatigue are present, or if known diabetes risk factors exist.

Not sure if this is normal? Chat with one of our pharmacists →

If you have received a result showing a raised fasting glucose alongside a normal HbA1c, it is important not to ignore the finding, even if you feel well. Arranging a review with your GP is advisable so that the result can be interpreted in the context of your full medical history, current medicines, and any relevant symptoms.

Seek same-day urgent medical assessment (call 999 or go to A&E) if you or someone else has any of the following, as these may indicate a serious acute condition such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS):

• Vomiting, abdominal pain, or rapid breathing alongside high blood glucose

• Drowsiness, confusion, or reduced consciousness

• Signs of severe dehydration

• Suspected type 1 diabetes with rapid onset of symptoms

Contact your GP promptly if you experience any of the following alongside an abnormal fasting glucose result:

• Increased thirst or frequent urination, particularly at night

• Unexplained fatigue or lethargy

• Blurred vision

• Slow-healing wounds or recurrent infections

• Unintentional weight loss

These symptoms may suggest that blood glucose is more significantly elevated than a single HbA1c result implies, and further investigation would be warranted.

Even in the absence of symptoms, a GP review is recommended if:

• Fasting glucose is 6.1 mmol/L or above

• You have known risk factors for type 2 diabetes, such as a family history, a BMI above 30 kg/m² (or above 27.5 kg/m² in people of South Asian, Chinese, or Middle Eastern ethnicity), or a history of gestational diabetes

• You are aged 40–74 and have not had a recent NHS Health Check (or aged 25–39 if you are of South Asian or Black African/Caribbean ethnicity, depending on local eligibility)

Repeat fasting glucose testing, a full lipid profile, kidney function tests, and blood pressure measurement are commonly requested alongside glucose results to build a comprehensive cardiovascular and metabolic risk picture. Early review allows for timely intervention if needed.

Lifestyle Factors That Can Affect Fasting Glucose Levels

Diet, physical inactivity, poor sleep, chronic stress, excess alcohol, and smoking can all raise fasting glucose independently of HbA1c by impairing insulin sensitivity or increasing hepatic glucose output.

Fasting glucose is particularly sensitive to lifestyle habits, and several modifiable factors can cause it to rise even when longer-term glucose control — as reflected by HbA1c — remains within the normal range.

Diet plays a significant role. Consuming a large, carbohydrate-rich meal in the evening can elevate fasting glucose the following morning, even after an overnight fast. Refined carbohydrates, sugary drinks, and alcohol are particularly likely to contribute to this effect. Conversely, a diet rich in fibre, wholegrains, vegetables, and lean protein — consistent with the NHS Eatwell Guide — supports more stable blood glucose levels.

Physical inactivity is another important factor. Regular physical activity improves insulin sensitivity, helping cells to take up glucose more efficiently. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, alongside muscle-strengthening activities on two or more days. Even a short walk after meals has been shown to reduce postprandial glucose spikes.

Sleep quality and duration are increasingly recognised as important determinants of glucose metabolism. Poor sleep — whether due to insomnia, shift work, or obstructive sleep apnoea (OSA) — can raise cortisol levels and impair insulin sensitivity, contributing to elevated fasting glucose. If you snore loudly, have witnessed pauses in breathing during sleep, or feel excessively sleepy during the day (particularly alongside obesity), it is worth discussing OSA with your GP, as treating it may help improve glucose regulation.

Stress is a frequently overlooked contributor. Chronic psychological stress activates the hypothalamic-pituitary-adrenal axis, leading to sustained cortisol elevation and consequent hepatic glucose release. Mindfulness, relaxation techniques, and adequate rest may help mitigate this effect.

Alcohol should be kept within NHS guidelines — no more than 14 units per week, spread over three or more days, with several alcohol-free days each week. Excess alcohol consumption is independently associated with impaired glucose regulation.

Smoking is also associated with increased insulin resistance and impaired glucose regulation. NHS Stop Smoking Services are available free of charge and can significantly improve your overall metabolic health.

Next Steps and Monitoring Recommendations

Repeat testing is the most important immediate step; confirmed impaired fasting glucose may prompt referral to the NHS Diabetes Prevention Programme and at least annual glucose monitoring.

A single discordant result — raised fasting glucose with a normal HbA1c — should be viewed as a prompt for closer monitoring rather than either reassurance or alarm. The appropriate next steps will depend on the degree of elevation, your individual risk profile, and the clinical context.

Repeat testing is the most important immediate step. NICE recommends that any abnormal glucose result in an asymptomatic person be confirmed on a separate occasion before clinical decisions are made. Your GP may arrange a repeat fasting glucose, an HbA1c, or an oral glucose tolerance test depending on the clinical picture.

If impaired fasting glucose or non-diabetic hyperglycaemia is confirmed, you may be referred to the NHS Diabetes Prevention Programme (NHS DPP), a structured, evidence-based lifestyle intervention. NHS England evaluations have shown that the programme supports meaningful reductions in weight and improvements in glucose levels, with a meaningful reduction in the risk of progression to type 2 diabetes in eligible participants. The programme covers dietary guidance, physical activity support, and behaviour change strategies.

Ongoing monitoring is recommended for those with confirmed NDH/IFG or other risk factors. This typically involves:

• At least annual fasting glucose or HbA1c testing (consider every 3–6 months if results are close to diagnostic thresholds or if medicines that can raise glucose have been started or changed)

• Regular blood pressure and cholesterol checks

• Weight and waist circumference monitoring

• Review of any medicines that may affect glucose

If you suspect that a medicine you are taking — such as a corticosteroid, antipsychotic, thiazide diuretic, or beta-blocker — may be contributing to raised glucose, discuss this with your prescriber. Do not stop any prescribed medicine without medical advice. Suspected adverse drug reactions can also be reported to the MHRA via the Yellow Card Scheme (yellowcard.mhra.gov.uk).

Self-monitoring of blood glucose at home is not routinely recommended for individuals without a diabetes diagnosis, but your GP can advise whether it would be appropriate in your specific circumstances.

Ultimately, a raised fasting glucose — even with a normal HbA1c — is a valuable early signal. Addressing modifiable risk factors promptly, maintaining regular contact with your GP, and attending any recommended follow-up appointments gives you the best opportunity to protect your long-term metabolic health.

Frequently Asked Questions